Key immune differences that make one West African ethnic group less susceptible to malaria identified

Updated on: March 19,2025

Key immune differences that make one West African ethnic group less susceptible to malaria identified

Updated on:March 19,2025

Rwanda reports 8 deaths linked to Ebola-like Marburg virus days after it declared an outbreak

by Ignatius SsuunaIn this Oct. 8, 2014 photo, a medical worker from the Infection Prevention and Control unit wearing full protective equipment carries a meal to an isolation tent housing a man being

Updated on: November 12,2024

Rwanda reports 8 deaths linked to Ebola-like Marburg virus days after it declared an outbreak

by Ignatius SsuunaIn this Oct. 8, 2014 photo, a medical worker from the Infection Prevention and Control unit wearing full protective equipment carries a meal to an isolation tent housing a man being

Updated on:November 12,2024

Study identifies active substance for the prevention of chlamydial infections

byMedical University of ViennaGraphical abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101643In order to find previously unknown substances for the treatment

Updated on: July 11,2024

Study identifies active substance for the prevention of chlamydial infections

byMedical University of ViennaGraphical abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101643In order to find previously unknown substances for the treatment

Updated on:July 11,2024

Small RNAs found to boost immune response to tuberculosis

by Roni Dengler,Thomas Jefferson UniversityCredit:Molecular Therapy - Nucleic Acids(2024). DOI: 10.1016/j.omtn.2024.102156Tuberculosis kills about 1.3 million people each year, makin

Updated on: September 11,2024

Small RNAs found to boost immune response to tuberculosis

by Roni Dengler,Thomas Jefferson UniversityCredit:Molecular Therapy - Nucleic Acids(2024). DOI: 10.1016/j.omtn.2024.102156Tuberculosis kills about 1.3 million people each year, makin

Updated on:September 11,2024

Concerns over potential harms of tests advertised directly to consumers

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainBetter information and regulation are essential to protect consumers from potential harms of tests advertised directly to consumers,&nbs

Updated on: December 10,2024

Concerns over potential harms of tests advertised directly to consumers

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainBetter information and regulation are essential to protect consumers from potential harms of tests advertised directly to consumers,&nbs

Updated on:December 10,2024

Mpox: Scientists offer better understanding of tecovirimat resistance

Updated on: March 17,2025

Mpox: Scientists offer better understanding of tecovirimat resistance

Updated on:March 17,2025

Travelers' phones pose potential risks to public health and biosecurity

byBond UniversityCredit:Infection, Disease & Health(2024). DOI: 10.1016/j.idh.2024.08.004Knowledge and ideas circulate freely at international conferences but so do germs carried

Updated on: November 13,2024

Travelers' phones pose potential risks to public health and biosecurity

byBond UniversityCredit:Infection, Disease & Health(2024). DOI: 10.1016/j.idh.2024.08.004Knowledge and ideas circulate freely at international conferences but so do germs carried

Updated on:November 13,2024

Increasing children's immunity to deadly diseases through improved vaccine strategy

by University College LondonField workers recruit participants for the pneumococcal vaccine study in Blantyre. Credit:Malawi Liverpool Wellcome Program.Offering a booster dose or changing t

Updated on: June 12,2024

Increasing children's immunity to deadly diseases through improved vaccine strategy

by University College LondonField workers recruit participants for the pneumococcal vaccine study in Blantyre. Credit:Malawi Liverpool Wellcome Program.Offering a booster dose or changing t

Updated on:June 12,2024

Study identifies unpredicted immune responses to adenoviral COVID-19 vaccines

byUniversity of LiverpoolCytokine profile displaying T-cell responses to ChAdOx1 nCoV-19 and Ad26.COV2. S in vaccine naïve donors. a) T-cell cytokine profile after 48 h exposure to ChAdOx1 nCoV-

Updated on: July 30,2024

Study identifies unpredicted immune responses to adenoviral COVID-19 vaccines

byUniversity of LiverpoolCytokine profile displaying T-cell responses to ChAdOx1 nCoV-19 and Ad26.COV2. S in vaccine naïve donors. a) T-cell cytokine profile after 48 h exposure to ChAdOx1 nCoV-

Updated on:July 30,2024

Optimized diagnosis of neuroborreliosis using signaling protein as a biomarker

by Karl Landsteiner University of Health SciencesCredit: Erik Karits from PexelsA newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis. Th

Updated on: July 11,2024

Optimized diagnosis of neuroborreliosis using signaling protein as a biomarker

by Karl Landsteiner University of Health SciencesCredit: Erik Karits from PexelsA newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis. Th

Updated on:July 11,2024

First mouse strain susceptible to severe COVID-19 without the need for genetic modification identified

byJackson LaboratoryOut of these eight strains of mice, only the CAST mouse was susceptible to SARS-CoV-2, including beta, omicron and delta variants. The eight strains include A/J, B6J, CAST, 1

Updated on: December 18,2024

First mouse strain susceptible to severe COVID-19 without the need for genetic modification identified

byJackson LaboratoryOut of these eight strains of mice, only the CAST mouse was susceptible to SARS-CoV-2, including beta, omicron and delta variants. The eight strains include A/J, B6J, CAST, 1

Updated on:December 18,2024

Scientists develop novel antibody platform that tackles viral mutations

byThe Mount Sinai HospitalAMETA treatment effectively clumps the virus and disarms its spike structures, which are essential for infecting host cells. Credit: Jialu Xu, Ph.D., University of Oxfo

Updated on: November 14,2024

Scientists develop novel antibody platform that tackles viral mutations

byThe Mount Sinai HospitalAMETA treatment effectively clumps the virus and disarms its spike structures, which are essential for infecting host cells. Credit: Jialu Xu, Ph.D., University of Oxfo

Updated on:November 14,2024